Stopping statins after stroke raises risk of death, dependency

Aug 27, 2007

People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the August 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

The study found that people who stopped taking their cholesterol-lowering drugs, also called statins, while hospitalized after a stroke were 4.7 times more likely to have died or be dependent on others for their care three months after the stroke than people who kept taking the drugs.

“These results strongly support the recommendation to physicians to continue statin drugs during the acute phase of an ischemic stroke,” said study author José Castillo, MD, PhD, of the University of Santiago de Compostela in Santiago de Compostela, Spain.

Castillo said that while no protocols suggest that patients should not receive statins after a stroke, in many cases the drugs are discontinued to avoid problems that can occur when stomach content is regurgitated into the lungs. “This study clearly shows the benefits of continuing statin use,” he said.

The study involved 89 people who were already taking the cholesterol-lowering drugs at the time when they had a stroke. For the first three days after being admitted to the hospital, 46 of the people received no statin drugs and 43 received the drugs.

After three months, 27 people, or 60 percent, of the group that received no statins had either died or were disabled to the point that they could not complete their daily activities independently, compared to 16 people, or 39 percent, of the group that kept taking statins.

Previous studies have shown that people who are taking statins at the time of a stroke have less severe strokes than those who aren’t taking statins.

Statins appear to do more than reduce cholesterol. They also reduce inflammation and help keep the blood from clotting, which can cause stroke. Statins also increase the release of nitric oxide, which is protective, from the cells lining artery walls.

Source: American Academy of Neurology

Explore further: Missing protein restored in patients with muscular dystrophy

add to favorites email to friend print save as pdf

Related Stories

Cholesterol: The good, the bad, the unknown

Feb 21, 2011

Two people are diagnosed with high cholesterol, one of the leading risk factors for heart disease, and follow similar therapies. One ends up with improved cholesterol levels, but the other doesn't.

Statin benefit 'not affected' by low inflammation

Jan 28, 2011

(PhysOrg.com) -- A new Oxford-led study shows that statins are at least as effective in reducing the risk of heart attack or stroke in patients with low levels of inflammation as they are in other patients.

Statins less dangerous than thought for liver patients

Nov 24, 2010

Long-term use of statins, a drug widely prescribed to prevent artery-blocking cholesterol, is less risky than thought for patients with a common form of liver disease, according to a study published on Wednesday by The La ...

Major international study to test new heart disease drug

Nov 18, 2010

(PhysOrg.com) -- A major international study to test whether a new type of cholesterol treatment can prevent coronary deaths and heart attacks will start in early 2011. The study will be coordinated by the ...

Recommended for you

Student seeks to improve pneumonia vaccines

9 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

10 hours ago

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

User comments : 0